OraSure Technologies, Inc. ("OraSure" and "OTI") is dedicated to revolutionizing health by providing actionable insights and facilitating the broader accessibility of healthcare. The company enhances the access, quality, and value of healthcare through innovative, user-friendly tests and advanced sample management solutions. Through its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., OTI has established itself as a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices. These products are designed to aid in the discovery and detection of critical medical conditions. OraSure's diverse portfolio is distributed globally to a wide range of clients, including clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and directly to consumers.